Literature DB >> 11336168

Orthotopic liver transplantation for idiopathic portal hypertension: indications and outcome.

J Dumortier1, T Bizollon, J Y Scoazec, M Chevallier, B Bancel, F Berger, C Ducerf, S Claudel-Bonvoisin, P Paliard, O Boillot, C Trepo.   

Abstract

BACKGROUND: Idiopathic portal hypertension is a rare clinical syndrome which may be associated with a spectrum of histological lesions, including nodular regenerative hyperplasia and incomplete septal cirrhosis. Here, we report eight adult patients with idiopathic portal hypertension who experienced an unusually severe clinical evolution characterized by the development of progressive hepatic failure requiring orthotopic liver transplantation. Our aims are: (a) to stress the distinctive clinical presentation of these patients, (b) to describe their biological and histopathological features, and (c) to evaluate the results of orthotopic liver transplantation in this rare indication.
METHODS: Complete clinical charts and histological data were available in all patients. All patients were male. Their age at diagnosis ranged from 17 to 59 years. Complications of portal hypertension revealed the disease in all cases. Medical treatment was performed in all patients and portosystemic shunt in three.
RESULTS: The development of progressive hepatic failure led to the indication of liver transplantation after a delay ranging from 3 to 10 years. Explanted livers showed pure nodular regenerative hyperplasia in three patients and incomplete septal cirrhosis in five. Recovery was uneventful. All patients are alive, without recurrence of the disease.
CONCLUSIONS: This report points to the existence of severe cases of idiopathic portal hypertension occurring without underlying or associated systemic disease and characterized by a poor clinical course and requiring liver transplantation.

Entities:  

Mesh:

Year:  2001        PMID: 11336168     DOI: 10.1080/003655201300051298

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

1.  Hepatoportal sclerosis in a child.

Authors:  Nur Arslan; Benal Buyukgebiz; Yesim Ozturk; Samil Hizli; Ozlem Bekem; Ozgül Sagol; Erdener Ozer
Journal:  Eur J Pediatr       Date:  2004-08-17       Impact factor: 3.183

2.  Noncirrhotic portal fibrosis: a rare cause of end-stage liver disease requiring liver transplantation.

Authors:  Sunil Taneja; Yogesh Chawla; Radha K Dhiman
Journal:  Hepatol Int       Date:  2011-09-03       Impact factor: 6.047

Review 3.  Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension.

Authors:  Marek Hartleb; Krzysztof Gutkowski; Piotr Milkiewicz
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

4.  Non-cirrhotic portal fibrosis related end stage liver disease in adults: evaluation from a study on living donor liver transplant recipients.

Authors:  Sanjiv Saigal; Nabeen C Nayak; Deepali Jain; Vinay Kumaran; Ravi Mohanka; Neeraj Saraf; Amit Rastogi; Naimesh Mehta; Samiran Nundy; Arvinder Soin
Journal:  Hepatol Int       Date:  2011-01-12       Impact factor: 6.047

5.  Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20-year cohort study in all Dutch liver transplant units.

Authors:  Berrie Meijer; Melek Simsek; Hans Blokzijl; Robert A de Man; Minneke J Coenraad; Gerard Dijkstra; Carin Mj van Nieuwkerk; Chris Jj Mulder; Nanne Kh de Boer
Journal:  United European Gastroenterol J       Date:  2016-11-16       Impact factor: 4.623

6.  Endothelial to mesenchymal transition via transforming growth factor-beta1/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension.

Authors:  Azusa Kitao; Yasunori Sato; Seiko Sawada-Kitamura; Kenichi Harada; Motoko Sasaki; Hiroyasu Morikawa; Susumu Shiomi; Masao Honda; Osamu Matsui; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

7.  Acute deterioration of idiopathic portal hypertension requiring living donor liver transplantation: a case report.

Authors:  Takamitsu Inokuma; Susumu Eguchi; Tetsuo Tomonaga; Kensuke Miyazaki; Koji Hamasaki; Hirotaka Tokai; Masaaki Hidaka; Kosho Yamanouchi; Mitsuhisa Takatsuki; Sadayuki Okudaira; Yoshitsugu Tajima; Takashi Kanematsu
Journal:  Dig Dis Sci       Date:  2008-10-31       Impact factor: 3.199

Review 8.  Causes and Management of Non-cirrhotic Portal Hypertension​.

Authors:  Stefania Gioia; Silvia Nardelli; Lorenzo Ridola; Oliviero Riggio
Journal:  Curr Gastroenterol Rep       Date:  2020-09-17

9.  Anticoagulant therapy for nodular regenerative hyperplasia in a HIV-infected patient.

Authors:  Florian Bihl; Filip Janssens; Francoise Boehlen; Laura Rubbia-Brandt; Antoine Hadengue; Laurent Spahr
Journal:  BMC Gastroenterol       Date:  2010-01-18       Impact factor: 3.067

Review 10.  Living donor liver transplantation for idiopathic portal hypertension with extrahepatic portal vein stenosis and splenic artery aneurysms: a case report and review of the literature.

Authors:  Shigeyuki Kawachi; Naokazu Chiba; Masashi Nakagawa; Toshimichi Kobayashi; Kosuke Hikita; Toru Sano; Koichi Tomita; Hiroshi Hirano; Yuta Abe; Hideaki Obara; Motohide Shimazu
Journal:  BMC Surg       Date:  2020-10-29       Impact factor: 2.102

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.